(Q34075969)

30 July 2017

1 reference

title

Why is there such difficulty in defining the natural history of hepatitis C? (English)

1 reference

30 July 2017

Seeff LB

1

1 reference

30 July 2017

1 October 2000

1 reference

30 July 2017

1 reference

30 July 2017

40

1 reference

30 July 2017

1161-1164

1 reference

30 July 2017

10

1 reference

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

30 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2000.40101161.X

Clinical outcomes after transfusion-associated hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2000.40101161.X

Prognosis of chronic hepatitis C: results of a large, prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2000.40101161.X

The pathology of hepatitis C as a function of mode of transmission: blood transfusion vs. intravenous drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2000.40101161.X

Non-A, non-B post-transfusion hepatitis. Looking back in the second decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2000.40101161.X

Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2000.40101161.X

Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in germany: a 20-year multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2000.40101161.X

Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2000.40101161.X

Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2000.40101161.X

Efficacy of prophylactic gamma-globulin in preventing non-A, non-B post-transfusion hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2000.40101161.X

Prevention of rheumatic fever; treatment of the preceding streptococcic infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2000.40101161.X

45-year follow-up of hepatitis C virus infection in healthy young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2000.40101161.X

Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2000.40101161.X

10.1046/J.1537-2995.2000.40101161.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

11061849